Corpus Intelligence IC Memo — FALLS COMMUNITY HOSPITAL AND CLINIC 2026-04-26 11:54 UTC
IC Memo — FALLS COMMUNITY HOSPITAL AND CLINIC
Investment Committee Memorandum | TX | 36 beds | Grade D | EBITDA uplift $229K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FALLS COMMUNITY HOSPITAL AND CLINIC

CCN 450348 | FALLS, TX | 36 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

FALLS COMMUNITY HOSPITAL AND CLINIC is a 36-bed community hospital in FALLS, TX with $2.9M in net patient revenue and a -73.3% operating margin. The hospital serves a payer mix of 27.5% Medicare, 0.0% Medicaid, and 72.5% commercial.

Thesis: Turnaround. Our ML models identify $229K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -73.3% to -65.4% (+785bps).

Net Revenue HCRIS$2.9M
Current EBITDA COMPUTED$-2.1M
Operating Margin COMPUTED-73.3%
Occupancy HCRIS1.2%
Revenue / Bed COMPUTED$81K
Net-to-Gross HCRIS19.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
282
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -73.3% places it below the state median. Among 282 size-comparable peers (18-72 beds), the median margin is -3.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-72), prioritizing same-state peers. 282 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FALLS COMMUNITY HOSPITAL AND C (Target)TX36$2.9M-73.3%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
BAYLOR MEDICAL CENTER AT FRISCTX68$161.1M10.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $229K (785bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$64K+221bp12mo
Net Collection Rate93.5%97.0%$61K+210bp18mo
Cost to Collect4.5%2.5%$58K+200bp12mo
A/R Days Reduction5200.0%3800.0%$36K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+33bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$64K
Net Collection Rate
$61K
Cost to Collect
$58K
A/R Days Reduction
$36K
Clean Claim Rate
$10K
Total EBITDA Uplift$229K
Current EBITDA$-2.1M
+ RCM Uplift+$229K
Pro Forma EBITDA$-1.9M
Current Margin-73.3%
Pro Forma Margin-65.4%
WC Released (1x)$112K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.3M$-11.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.3M$-14.1M0.00x-100.0%
Bull Case9.0x11.0x$-3.0M$-14.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.0M$-16.6M0.00x-100.0%
Bear Case11.0x10.0x$-3.6M$-11.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.6M$-14.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 1.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 282 hospitals with 18-72 beds
  • Same-state prioritization (n=283)
  • Comp margins: P25=-26.1% / P50=-3.9% / P75=10.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.